Longitude Capital Partners Ii, LLC

Aimmune Therapeutics, Inc.

10% Owner

Avg. Two Year Performance

121% Avg. Purchase Return    49% Compound
No Sale Track Record

Holdings: 6.02M shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount
Buy:0--
Sell:0--

Sentiment

Insider Trading Sentiment: Hold

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment:
Insider Trading Sentiment:
Insider Trading Sentiment:

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Sentiment

Company Sentiment

Most Recent Insider Transactions